Dow Chemicals and Izolan Form Joint Venture to Provide Polyurethane to Russia

The Dow Chemical Company and Izolan announced today the formation of a joint venture company that will provide customer-tailored, polyurethane systems products to a growing customer base in Russia. Subject to regulatory and other customary approvals, the new company, Dow Izolan, will be based in Vladimir, a city 170km north east of Moscow.

Dow Izolan will combine Dow's Polyurethane Systems business, known for its global leadership position in technology and raw materials back integration, with Izolan's strong local customer focus, product positioning and market experience, to become the leader in Russia's polyurethane systems house marketplace.

The new company will employ more than hundred employees, mainly from Izolan's current site in Vladimir. Further, the joint venture plans to build a new, large, state-of-the-art production plant in the Vladimir area within the next two years. The new facility will produce a broad variety of polyurethane systems products to meet the growing needs of customers in the region.

"Dow and Izolan have been working together since the 1990s on various commercial projects," said Mikhail Tsarfin, general manager of Izolan and designated commercial director for Dow Izolan. "This new joint venture — which harnesses a detailed understanding of polyurethane chemistry, an in-depth knowledge of the polyurethane systems market and a proven track record of customer commitment — is poised to become the leader in Russia's polyurethane systems house marketplace," Tsarfin added.

"Over the past few years, Dow's Polyurethane Systems business has been growing consistently through acquisitions and joint ventures and has established a solid reputation for providing reliable, high-performance and high-quality polyurethanes systems products" stated Juan Antonio Merino, global general manager for Dow Polyurethane Systems. "Our joint venture with Izolan marks an important step in supporting Dow's global leadership position in polyurethane systems." Merino added.

"Since 1974, Dow has been providing quality products and services to our customers in Russia and the CIS," stated Adriaan van den Berge, general manager for Dow Europe in Russia. "The creation of the Dow Izolan joint venture is the latest example of Dow's commitment to building solid businesses in the region." van den Berge added.

"This joint venture demonstrates Dow's continued commitment to invest in our Performance businesses and to grow in emerging geographies," stated Pat Dawson, vice president for Dow Polyurethanes. "By blending the strengths of both our companies, we are establishing the foundation for a strong and successful partnership that will better serve the needs of customers, accelerate innovation and provide opportunities for additional investment in the region." Dawson added.better serve the needs of customers, accelerate innovation and provide opportunities for additional investment in the region." Dawson added.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dow Chemicals. (2019, March 02). Dow Chemicals and Izolan Form Joint Venture to Provide Polyurethane to Russia. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=6271.

  • MLA

    Dow Chemicals. "Dow Chemicals and Izolan Form Joint Venture to Provide Polyurethane to Russia". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=6271>.

  • Chicago

    Dow Chemicals. "Dow Chemicals and Izolan Form Joint Venture to Provide Polyurethane to Russia". AZoM. https://www.azom.com/news.aspx?newsID=6271. (accessed November 21, 2024).

  • Harvard

    Dow Chemicals. 2019. Dow Chemicals and Izolan Form Joint Venture to Provide Polyurethane to Russia. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=6271.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.